| Attributes | Values |
|---|
| rdf:type
| |
| description
| - article scientifique publié en 2006 (fr)
- artículu científicu espublizáu en 2006 (ast)
- наукова стаття, опублікована в березні 2006 (uk)
- 2006 թվականի մարտին հրատարակված գիտական հոդված (hy)
- 2006 թուականի Մարտին հրատարակուած գիտական յօդուած (hyw)
- مقالة علمية (نشرت في مارس 2006) (ar)
- wetenschappelijk artikel (gepubliceerd in 2006-03) (nl)
- scientific article (publication date: March 2006) (en)
- im März 2006 veröffentlichter wissenschaftlicher Artikel (de)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| cites work
| |
| cites work
| |
| author name string
| |
| OpenCitations bibliographic resource ID
| |
| OpenCitations bibliographic resource ID
| |
| author name string
| - Williams PM
- Chen R
- Colman H
- Kharbanda S
- Misra A
- Feuerstein BG
- Soroceanu L
- Phillips HS
- Modrusan Z
- Wu TD
- Aldape K
- Forrest WF
- Nigro JM
- Soriano RH
|
| OpenCitations bibliographic resource ID
| |
| rdfs:label
| - Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis (en)
- Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis (ast)
|
| skos:prefLabel
| - Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis (en)
- Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis (ast)
|
| name
| - Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis (en)
- Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis (ast)
|
| title
| |
| title
| - Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1016/J.CCR.2006.02.019
|
| ResearchGate publication ID
| |
| ResearchGate publication ID
| |
| is about
of | |
| is cites work
of | - Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
- Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
- Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging
- TWIST1 promotes invasion through mesenchymal change in human glioblastoma
- Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
- Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts
- Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
- The perivascular niche microenvironment in brain tumor progression
- Genetic modeling of gliomas in mice: new tools to tackle old problems
- Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression
- A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.
- Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules
- Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence
- Neurosphere formation is an independent predictor of clinical outcome in malignant glioma
- Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights
- Paediatric and adult malignant glioma: close relatives or distant cousins?
- Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.
- IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
- Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma
- The human orphan nuclear receptor tailless (TLX, NR2E1) is druggable
- Intra-arterial chemotherapy for malignant gliomas: a critical analysis
- Detoxification of oxidative stress in glioma stem cells: mechanism, clinical relevance, and therapeutic development
- Identification of molecular pathways facilitating glioma cell invasion in situ
- PTEN in brain tumors
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)